Clolar (clofarabine recalls

The FDA has published 1 recall involving Clolar (clofarabine since 2017. The latest was reported on 22 Nov 2017. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2017

Last 12 months0reported

Class I00% of total

Ongoing0latest 22 Nov 2017

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 1 100%

Why clolar (clofarabine is recalled

Packaging Defects1100%

Companies

Genzyme1100%

By year

20171100%

All clolar (clofarabine recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
22 Nov 2017Drug	CLASS III	Clolar (clofarabine) 20 mg/ (1 mg/mL) Injection, for intravenous use recalled	Genzyme	Packaging Defects	Nationwide

Should you stop taking Clolar (clofarabine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.